Estimated Half-Life of SARS-CoV-2 Anti-Spike Antibodies More Than Double the Half-Life of Anti-nucleocapsid Antibodies in Healthcare Workers.
作者信息
Van Elslande Jan, Gruwier Lien, Godderis Lode, Vermeersch Pieter
机构信息
Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, Leuven, Belgium.
Environment and Health, Department of Public Health and Primary Care, KU Leuven , Leuven, Belgium.
出版信息
Clin Infect Dis. 2021 Dec 16;73(12):2366-2368. doi: 10.1093/cid/ciab219.
Abstract
摘要
相似文献
1
Estimated Half-Life of SARS-CoV-2 Anti-Spike Antibodies More Than Double the Half-Life of Anti-nucleocapsid Antibodies in Healthcare Workers.
Clin Infect Dis. 2021 Dec 16;73(12):2366-2368. doi: 10.1093/cid/ciab219.
2
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
Clin Infect Dis. 2021 Aug 2;73(3):e699-e709. doi: 10.1093/cid/ciab004.
3
SARS COV-2 anti-nucleocapsid and anti-spike antibodies in an emergency department healthcare worker cohort: September 2020 - April 2021.
Am J Emerg Med. 2022 Apr;54:81-86. doi: 10.1016/j.ajem.2022.01.055. Epub 2022 Feb 2.
4
SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study.
Viruses. 2022 Sep 4;14(9):1966. doi: 10.3390/v14091966.
5
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
N Engl J Med. 2021 Feb 11;384(6):533-540. doi: 10.1056/NEJMoa2034545. Epub 2020 Dec 23.
6
Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in Iran.
J Med Virol. 2022 Dec;94(12):5669-5677. doi: 10.1002/jmv.28029. Epub 2022 Aug 4.
7
Evolution of anti-SARS-CoV-2 immune response in a cohort of French healthcare workers followed for 7 months.
Infect Dis Now. 2022 Mar;52(2):68-74. doi: 10.1016/j.idnow.2022.01.004. Epub 2022 Jan 19.
8
Serological Screening of Immunoglobulin G against SARS-CoV-2 Nucleocapsid and Spike Protein before and after Two Vaccine Doses among Healthcare Workers in Japan.
Tohoku J Exp Med. 2022 May 27;257(1):57-64. doi: 10.1620/tjem.2022.J017. Epub 2022 Mar 31.
9
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection.
PLoS One. 2022 Jan 12;17(1):e0262169. doi: 10.1371/journal.pone.0262169. eCollection 2022.
10
Incidence of SARS-CoV-2 re-infection in anti-nucleocapsid IgG-positive healthcare workers: a prospective cohort study.
Ir J Med Sci. 2023 Apr;192(2):915-918. doi: 10.1007/s11845-022-02997-w. Epub 2022 Apr 12.
引用本文的文献
1
Placental transfer of SARS-CoV-2 antibodies in mother-neonate pairs: a prospective nested cohort study.
BMC Infect Dis. 2025 Jul 1;25(1):875. doi: 10.1186/s12879-025-11225-6.
2
Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection.
PLoS One. 2025 Jun 11;20(6):e0325923. doi: 10.1371/journal.pone.0325923. eCollection 2025.
3
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories.
Nat Commun. 2025 May 14;16(1):4466. doi: 10.1038/s41467-025-57370-z.
4
Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children.
Front Immunol. 2025 Feb 26;16:1521299. doi: 10.3389/fimmu.2025.1521299. eCollection 2025.
5
SARS-CoV-2 evolution on a dynamic immune landscape.
Nature. 2025 Mar;639(8053):196-204. doi: 10.1038/s41586-024-08477-8. Epub 2025 Jan 29.
6
Seroprevalence of SARS-CoV-2 in wet market workers in Dhaka, Bangladesh in 2022.
IJID Reg. 2024 Nov 24;14:100497. doi: 10.1016/j.ijregi.2024.100497. eCollection 2025 Mar.
7
Longevity of hybrid immunity against SARS-CoV-2 in adults vaccinated with an adenovirus-based COVID-19 vaccine.
BMC Infect Dis. 2024 Sep 12;24(1):959. doi: 10.1186/s12879-024-09891-z.
8
Minding the margins: Evaluating the impact of COVID-19 among Latinx and Black communities with optimal qualitative serological assessment tools.
PLoS One. 2024 Jul 25;19(7):e0307568. doi: 10.1371/journal.pone.0307568. eCollection 2024.
9
The Long-Term Immunogenicity of mRNABNT162b Third Vaccine Dose in Solid Organ Transplant Recipients.
Vaccines (Basel). 2024 Feb 22;12(3):224. doi: 10.3390/vaccines12030224.
10
Enhanced immunity against SARS-CoV-2 in returning Chinese individuals.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2300208. doi: 10.1080/21645515.2023.2300208. Epub 2024 Jan 8.
Zotero 插件